Oak HC/FT

“Vumedi raised a $104 million Series B round from Oak HC/FT.”

“Alterra Labs, a one-year-old New York startup that builds simulated medical environments for testing and training AI models on clinical tasks, raised a $12.5 million seed round led by Oak HC/FT.”

“Vitalize raised $31 million from Oak HC/FT on October 6, 2026. Clinical operations software for staffing and scheduling.”

“Halluminate's $30 million round from Oak HC/FT”

“Halluminate... builds benchmarks and simulated environments for training and evaluating AI agents on financial-services tasks, raised a $30 million Series A round led by Oak HC/FT.”

“Halluminate, an SF-based developer of AI training environments for financial work, raised $30m in Series A funding.”

“In December 2025, Oak HC/FT and General Catalyst co-led Chai's $130M Series B at a $1.3B valuation.”

“Across 40+ years she has managed $14B, backed 70+ successful exits and 15 IPOs, and been named the top healthcare investor on the Forbes Midas List.”

“Example of Oak building a company from the idea stage with a $100M day-one commitment... Total funding is now $150M.”

“Healthcare/fintech VC, $14B managed historically, $7B+ currently across 100+ companies; Fund VI of nearly $2B.”

“Brad Smith brought Oak Aspire Health, a palliative care model, after the firm had looked for one for 15 to 20 years.”

“Oak invested last year [in Chai Discovery].”

“Oak committed $100 million up front [to Augur]... we committed $100 million to them up front.”

“Dash Bio: AI and robotics for automated drug-development bioanalysis, $30M from Oak HC/FT”